IBD is not "a bad gut day."
Inflammatory bowel disease — Crohn's disease and ulcerative colitis — is chronic, immune-mediated inflammation of the gastrointestinal tract. It is not bloating after a heavy meal. It is not occasional irregularity or a stretch of stress-related stomach trouble. These things happen to most people and are worth paying attention to. IBD is a different category entirely: a relapsing, potentially serious condition that can cause lasting tissue damage and requires actual medical management. Conflating the two doesn't help anyone, and it's a conflation that's become very easy to make when gut health content treats every digestive complaint as part of the same continuum.
What the microbiome research actually shows
The connection between the gut microbiome and IBD is real and well-documented. People with Crohn's and ulcerative colitis consistently show dysbiotic microbial profiles: lower Bifidobacterium, significantly depleted Faecalibacterium prausnitzii (a butyrate-producing species associated with anti-inflammatory activity), and elevated Proteobacteria. These shifts are reproducible across studies and patient populations.
What the research doesn't yet tell us is whether this dysbiosis causes IBD, results from it, or — most likely — both. The gut environment in active inflammation is hostile to many commensal species, which means dysbiosis can be self-reinforcing. But that's different from saying that fixing the microbiome fixes the disease. The association is robust; the causality is not settled. Treating the microbiome as the primary lever for managing IBD is getting ahead of what the evidence supports.
What probiotics can and can't do here
GoodOnes are built for structure/function support — everyday gut health for people who want to maintain a well-functioning digestive system. That's a legitimate and meaningful category. It is not IBD treatment, and we won't position it as such.
Each strain in our formulas has a specific, documented job — that's the whole premise behind the one strain, one job approach. But "supports digestive comfort" and "manages active intestinal inflammation" are not the same job. For someone in an IBD flare, especially Crohn's, a probiotic bought on the internet is not the right tool. The right move is a gastroenterologist — someone who can assess disease activity, adjust therapy, and monitor for complications.
For medically complex cases, Flore Clinical is Flore Inc.'s clinician-supervised arm. That's the appropriate tier for people who need professional oversight of their gut health protocol — not a consumer product, however good the formulation.
For people with IBD who are in remission and want daily gut support alongside their existing medical management, that's a conversation that belongs with their gastroenterologist — not something to navigate alone based on marketing copy. The Regular One is built for everyday gut function in otherwise healthy adults. Disease management is a different job, and it requires different tools, different oversight, and a different level of accountability than anything we sell.